Bristol Myers Squibb (BMY)

Depreciation & Amortization

$3.18B

TTM · Period ending: · USD

BMY logo

BMY Depreciation & Amortization

Latest reported$3.18B
BMY TTM Depreciation & Amortization ($244.00M → $3.18B)
High-resolution chart · PNG

BMY depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
3,176,000,000
3,593,000,000
4,011,000,000
4,914,000,000
6,495,000,000
8,080,000,000
9,600,000,000
10,184,000,000
10,027,000,000
9,863,000,000
9,760,000,000
9,817,000,000
9,970,000,000
10,121,000,000
10,276,000,000
10,334,000,000
10,473,000,000
10,602,000,000
10,686,000,000
10,797,000,000
10,725,000,000
10,571,000,000
10,380,000,000
8,926,000,000
6,442,000,000
4,053,000,000
1,746,000,000
682,000,000
676,000,000
664,000,000
637,000,000
662,000,000
685,000,000
739,000,000
789,000,000
714,000,000
631,000,000
510,000,000
382,000,000
336,000,000
336,000,000
337,000,000
376,000,000
403,000,000
410,000,000
434,000,000
467,000,000
545,000,000
613,000,000
687,000,000
763,000,000
781,000,000
796,000,000
755,000,000
681,000,000
689,000,000
580,000,000
638,000,000
689,000,000
680,000,000
762,000,000
747,000,000
744,000,000
745,000,000
758,000,000
744,000,000
724,000,000
705,000,000
706,000,000
732,000,000
816,000,000
890,000,000
921,000,000
927,000,000
892,000,000
872,000,000
889,000,000
917,000,000
927,000,000
932,000,000
919,000,000
912,000,000
929,000,000
945,000,000
966,000,000
948,000,000
909,000,000
886,000,000
839,000,000
812,000,000
786,000,000
740,000,000
737,000,000
734,000,000
735,000,000
797,000,000
746,000,000
742,000,000
748,000,000
686,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.